✦ LIBER ✦

108 POSTER Phase I study of ABT869, a multiple receptor tyrosine kinase inhibitor, in patients with refractory solid malignancies.

✍ Scribed by B.C. Goh; C.H. Thang; N. Sukri; C.I. Wong; R. Soo; R. Carr; S.C. Lee; C.S. Chen; R. Humerickhouse

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I clinical trial of CEP-2563 dihyd

✍ Samir D. Undevia; Nicholas J. Vogelzang; Ann M. Mauer; Linda Janisch; Sridhar Ma 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 147 KB

Phase I, pharmacokinetic, and biological

✍ Haruyasu Murakami; Yutaka Ueda; Tatsu Shimoyama; Noboru Yamamoto; Yasuhide Yamad 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 278 KB

P-359 Results from a phase I study of th

✍ Wheeler, Catherine; Minami, Hironobu; Ebi, Hiromichi; Tahara, Makoto; Sasaki, Ya 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Effects of ZD6474, an orally active inhi

✍ S. Holden; S. Eckhardt; R. Basser; D. Rischin; H. Hurwitz; R. DeBoer; M. Rosenth 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Phase I and pharmacokinetic study of TSU

✍ Yutaka Ueda; Tatsu Shimoyama; Haruyasu Murakami; Noboru Yamamoto; Yasuhide Yamad 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 472 KB

A phase I study of pegylated liposomal d

✍ Wang-Gillam, Andrea; Thakkar, Nilay; Lockhart, A. Craig; Williams, Kerry; Baggst 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 282 KB